+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)

Results for tag: "Atosiban"

Global and Chinese Atosiban Industry, 2021 Market Research Report - Product Thumbnail Image

Global and Chinese Atosiban Industry, 2021 Market Research Report

  • Report
  • January 2021
  • 146 Pages
  • China, Global
From
From
  • 3 Results (Page 1 of 1)
Loading Indicator

Atosiban is a drug used in the field of Sexual and Reproductive Health (SRH). It is a synthetic oxytocin receptor antagonist, used to inhibit preterm labor in pregnant women. It is administered intravenously or intramuscularly, and is used to delay labor for up to 48 hours. Atosiban is also used to reduce the frequency and intensity of uterine contractions in women with preterm labor. Atosiban is a relatively new drug, and is not widely available in many countries. It is approved for use in Europe, but is not approved in the United States. In Europe, it is used in combination with other SRH drugs, such as magnesium sulfate and betamethasone. Atosiban is manufactured by several companies, including Ferring Pharmaceuticals, Teva Pharmaceuticals, and Mylan. It is also available in generic form from several generic drug manufacturers. Show Less Read more